ArticleInternational journal of general medicine2025
The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Maintenance Hemodialysis Patients.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of sex on the association between neutrophil percentage-to-albumin ratio and mortality in perioperative patients with chronic kidney disease: a retrospective analysis of the INSPIRE database.Perioperative medicine (London, England) · 2026Article
- Value of the neutrophil percentage-to-albumin ratio in predicting intravenous Immunoglobulin resistance in Kawasaki disease: a retrospective cohort study.Italian journal of pediatrics · 2025Article
- Prognostic value of neutrophil percentage-to-albumin, uric acid-to-creatinine, and CRP-to-albumin ratios for mortality in patients on maintenance hemodialysis.Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neutrophil percentage-to-albumin ratio (NPAR), dually reflecting inflammation and malnutrition, is related to poor prognosis closely in a range of diseases. However, prognostic value of NPAR in maintenance hemodialysis (MHD) patients remains to be confirmed. This study aimed to investigate the association between NPAR and all-cause mortality in MHD patients. Methods: Patients undergoing maintenance hemodialysis in the blood purification department of The First Affiliated Hospital of Guangxi Medical University from January 2021 to June 2021 were prospectively studied. NPAR was calculated by dividing neutrophils percentage by Albumin. Participants were followed for 36 months, with all-cause mortality as the primary endpoint. Results: There were 146 male and 80 female MHD patients included in this study, with a median age of 56 years. 53 (23.5%) patients died during the follow-up period. Kaplan-Meier (K-M) analysis revealed significantly lower survival in patients with high NPAR (>16.96) compared to those with low NPAR (≤16.96) (log rank test p=0.000). Multivariate Cox regression has identified NPAR as an independent predictor of all-cause mortality (HR=1.346, 95% CI 1.192-1.521, p=0.000). Receiver operating characteristic (ROC) analysis demonstrated that the Area Under the Curve (AUC) of NPAR was 0.821 (95% CI: 0.759-0.882, p=0.000) and had a trend to be better than that of neutrophil-to-lymphocyte ratio (NLR; AUC=0.710), platelet-to-lymphocyte ratio (PLR; AUC=0.647), neutrophil count (AUC=0.606), albumin (ALB; AUC=0.752), and high-sensitivity C-reactive protein (hs-CRP; AUC=0.670). Conclusion: NPAR is independently associated with all-cause mortality in MHD patients and may serve as an emerging indicator for risk stratification and prognostic management for this group of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.